Financials in USD. Standardized financial statements.
A compact view of how Interpharm Holdings, Inc. turns revenue into operating income and net income.
| Metric | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2001 | FY 2000 | FY 1999 | FY 1998 | FY 1997 | FY 1996 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $75.59M | $63.35M | $39.91M | $41.10M | $39.03M | $53.05M | $71.94M | $107.40M | $187.20M | $100.80M |
| Revenue Growth? | +19.3% | +58.7% | -2.9% | +5.3% | -26.4% | -26.3% | -33.0% | -42.6% | +85.7% | 0.0% |
| Cost of Revenue? | $53.92M | $45.93M | $30.84M | $31.30M | $33.60M | $46.77M | $60.08M | $96.00M | $173.30M | $91.00M |
| Gross Profit? | $21.67M | $17.43M | $9.07M | $9.79M | $5.43M | $6.28M | $11.86M | $11.40M | $13.90M | $9.80M |
| Gross Margin? | +28.7% | +27.5% | +22.7% | +23.8% | +13.9% | +11.8% | +16.5% | +10.6% | +7.4% | +9.7% |
| Operating Expenses? | $32.41M | $22.20M | $9.17M | $4.74M | $6.89M | $10.84M | $11.52M | $13.40M | $9.10M | $7.20M |
| Operating Income? | -$10.74M | -$4.77M | -$95,000 | $5.06M | -$1.46M | -$4.55M | $338,865 | -$2.00M | $4.80M | $2.60M |
| EBITDA? | -$8.18M | -$3.23M | $1.15M | $5.95M | -$1.30M | -$4.14M | $800,368 | -$1.30M | $5.30M | $2.90M |
| Income Before Tax | -$13.87M | -$5.49M | -$222,000 | $5.11M | -$1.61M | -$4.49M | $398,478 | -$4.90M | $4.80M | $3.00M |
| Income Tax Expense | $190,000 | -$1.70M | -$73,000 | $1.99M | $63,678 | $38,268 | $101,525 | -$600,000 | $2.10M | $1.30M |
| Net Income? | -$14.06M | -$3.79M | -$149,000 | $3.12M | -$1.68M | -$4.53M | $296,953 | -$4.30M | $2.70M | $1.70M |
| EPS? | $-0.26 | $-0.15 | $-0.01 | $0.16 | $-0.24 | $-0.64 | $0.04 | $-0.62 | $0.45 | $0.30 |
| Diluted EPS? | $-0.26 | $-0.15 | $-0.01 | $0.04 | $-0.24 | $-0.64 | $0.04 | $-0.62 | $0.43 | $0.30 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality